Search results
Excellent Ratings for Pfizer's Property Captive in Vermont Are Affirmed
Insurance Journal· 1 day agoAM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit...
Pfizer reports patient death in Duchenne gene therapy study
Reuters· 3 days ago, opens new tab experimental gene therapy being tested in a mid-stage trial for a muscle-wasting...
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Lawsuits
Bloomberg· 3 days agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
JD Supra: Routine Optimization of Result-Effective Variable Can Bridge Gaps in Prior Art
JD Supra· 9 hours agoSummary: Evidence that a claimed parameter is recognized as a result-effective variable can overcome the lack of explicit disclosure of the exact parameter in the prior art. Merck and Sanofi ...
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields - ...
Benzinga· 17 hours agoTraders can sort through Benzinga's extensive database of analyst ratings, including by analyst...
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga· 2 days agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s PFE experimental gene...
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 3 days agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Pfizer agrees to settle over 10,000 Zantac lawsuits
New Hampshire Union Leader· 3 days agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported...
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 4 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks· 1 day agoPatient Death in Pfizer’s Phase II DMD Study: Pfizer issued a community letter informing of the death of a patient who participated in its ongoing phase ...